The Relationship between Antipsychotic Drug Use and Liver Enzyme Levels in People with Mental Disorders
Abstract
The long-term use of some drugs causes side effects in the form of elevated liver enzyme levels. Meanwhile, antipsychotic drug therapy in people with mental disorders induces liver injury which leads to an elevation in serum glutamic oxaloacetic and pyruvic transaminases. Therefore, this study aims to analyze the relationship between the uses of antipsychotic drugs with elevated liver enzymes in people with mental disorders. This observational study used a cross-sectional design that included 69 people with mental disorders. The respondents were selected based on consecutive non-random sampling, while the data were collected using a questionnaire to obtain the universal characteristics of the subjects, therapy duration, and antipsychotic type, as well as an examination of AST and ALT levels using the ultraviolet test method. Furthermore, data analysis was conducted using the chi-Square test with a significance level of p<0.05. The results showed that thirty-two among the respondents or 46.4% used atypical antipsychotics, while 37 or 73.0% received the drugs for 1-6 months. In the subjects receiving typical antipsychotics, 10 or 55.6% had a significant elevation in liver enzymes compared to others receiving atypical antipsychotics namely 6 (18.8%) or a combination of both drugs namely 6 (31.6%). Therefore, the type of antipsychotic used in therapy has a significant relationship with elevated liver enzymes in people with mental disorders (p=0.028).
Keywords: antipsychotics, drugs, elevated
Keywords:
antipsychotics, drugs, elevatedDOI
https://doi.org/10.22270/jddt.v12i1.5266References
Chloe MM. Biochemical diagnosis of Wilson disease. clinical translational perspectives on Wilson disease, 2019; 237-48. https://doi.org/10.1016/B978-0-12-810532-0.00021-5
Vukotic NT, Dordevic J, Pejic S, Dordevic N, Pajovic SB. Antidepressant- and antipsychotics- induced hepatotoxicity. Archives of Toxicology, 2021; 95:767-89. https://doi.org/10.1007/s00204-020-02963-4
Qinyu LV, Zhenghui YI. Antipsychotic drugs and liver injury. Shang Arch Psych, 2018; 30(1):47-51. https://doi.org/10.11919/j.issn.1002-0829.217090
Aithal GP, Watkins PB, Andrade RJ et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89:806-815. https://doi.org/10.1038/clpt.2011.58
Zaini S, Ahmad NA. Chronic liver disease in patients with schizophrenia: a review. Malays J Psychiatry. 2018; 27(2):1-12.
López-Torres E, Süveges A, Peñas-Lledó EM, Doña A, Dorado P, Llerena A, et al. Liver enzyme abnormalities during antipsychotic treatment: a case report of risperidone - associated hepatotoxicity. Drug Metabol Drug Interact, 2014; 29(2); 123-6. https://doi.org/10.1515/dmdi-2013-0064
Julaeha, Ananda V, Pradana D. Overview of antipsychotic side effects in schizophrenic patients in an inpatient ward at Grhasia Hospital, Yogyakarta. Farmasains, 2016; 3(1):35-41
World Health Organization. Adolescent Mental Health 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health
Kementerian Kesehatan Republik Indonesia. Riskesdas 2018. Available from: https://www.kemkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf
Curtis LH, Masselink LE, ØstbyeT, Hutchison S, Dans pe, Wright A, et al. Prevalence of atypical antipsychotic drug use among commercially insured youths in The United States. Arch Pediatr Adolesc Med, 2005; 159:362-6. https://doi.org/10.1001/archpedi.159.4.362
Anjelisa T, Ruhi S. Pengaruh pemberian obat terhadap tingginya kadar enzim serum glutamate oksaloasetat transaminase (SGOT) dan serum glutamate piruvat transaminase (SGPT) pada pasien gangguan jiwa di RS Jiwa Provinsi Sulawesi Tenggara. Jurnal MediLab Mandala Waluya Kendari. 2018; 2(1):49-52.
Yulianty MD, Cahaya N, Srikartika VM. Antipsychotics use and side effects in patients with schizophrenia at Sambang Lihum Hospital South Kalimantan, Indonesia. Jurnal Sains Farmasi dan Klinis. 2017; 3(2):153-64. https://doi.org/10.29208/jsfk.2017.3.2.108
Cahyaningtyas, Rahmatini, Sedjahtera K. Hubungan Lama Terapi Antipsikotk dengan Kadar SGOT dan SGPT pada Pasien Skizofrenia di RSJ Prof. H. B Sa'anin Padang Tahun 2013. Jurnal Kesehatan Andalas. 2017; 6(1):128-33. https://doi.org/10.25077/jka.v6i1.658
Canuso CM, Pandina G. Gender and schizophrenia. Psychopharmacol Bull, 2007; 40(4):178-90.
Jarut YM, Fatimawati, Wiyono IW. Tinjauan penggunaan antipsikotik pada pengobatan skizofrenia di rumah sakit Prof.dr.V.I Ratumbuysang Manaso periode Januari 2013-Maret 2013. Pharmacon, 2013; 2(3):54-7. https://doi.org/10.35799/pha.2.2013.2378
Choi KH, Higgs BW, Weis S, Song J, Llenos K, Dulay JR, et al. Effects of typical and atypical antipsychotic in the liver of schizophrenia subjects. BMC Psychiatry, 2009; 9:57. https://doi.org/10.1186/1471-244X-9-57
Joseph N (2021) Antipsychotics advantages, disadvantages and treatment. J Bioequiv Availab. s1: e001
Indira H, Sudayasa IP, Uddu WSS, Imran M, Yakin A. Pengaruh minuman tradisional komeko terhadap kadar SGOT, SGPT, dan jaringan hati mencit (Mus musculus). Pharmauho, 2017; 4(1):23-5. http://dx.doi.org/10.33772/pharmauho.v3i1.3449
Marwick K, Walker SW, Taylor M. Antipsychotics and abnormal liver function tests: a systematic review. Clin Neuropharm, 2012; 35(5):244-53. https://doi.org/10.1097/WNF.0b013e31826818b6
Dutta SK, Chakravarty PJ, Borah AJ. A Case Report on haloperidol-induced hepatotoxicity. Ann Psychiatr Clin Neurosci, 2020; 3(1):1-3
Correia DT, Barbosa A, Pinto HC, Compos C, Rocha NBF, Machado S. Psychotropic drugs and liver disease : a critical review of pharmacokinetics and liver toxicity. World J Gastrointest Pharmacol Ther, 2017; 8(1):26-38. https://doi.org/10.4292/wjgpt.v8.i1.26
Manceaux P, Constant E, Zdanowicz N, Jacques D, Reynaert C. Management of marked liver enzymes increases during olanzapine treatment: a case report and review of the literature. Psychiatry Danubina, 2011; (23):15-17
Correia DT, Barbosa A, Pinto HC, Compos C, Rocha NBF, Machado S. Psychotropic drugs, and liver disease: a critical review of pharmacokinetics and liver toxicity. World J Gastrointest Pharmacol Ther. 2017; 8(1):26-38. https://doi.org/10.4292/wjgpt.v8.i1.26
El Sheikh WM, Rajab AZ, Shalaby AS, Shaheen AG. Comparison between typical and atypical antipsychotics according to their effects on metabolism in schizophrenia patients. Menofia Med J, 2019; 32(1):80-7. https://doi.org/10.4103/mmj.mmj_645_17
Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: a review. J Appl Pharm Sci. 2012; 2(5)233-43. https://doi.org/10.7324/JAPS.2012.2541
Published
Abstract Display: 725 
PDF Downloads: 633 PDF Downloads: 903 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.